Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
Clinical trial NCT00255528 · COMPLETED
Trial details
- NCT number
- NCT00255528
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.